Glycosyltransferase ST6GAL1 contributes to the regulation of pluripotency in human pluripotent stem cells

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Wang, Yu Chieh ^a,b   Stein, Jason W ^b   Lynch, Candace L ^b   Tran, Ha T ^b   Lee, Chia Yao ^b   Coleman, Ronald ^b   Hatch, Adam ^c   Antontsev, Victor G ^c   Chy, Hun S ^d,e   O'Brien, Carmel M ^d,e   Murthy, Shashi K ^c   Laslett, Andrew L ^d,e   Peterson, Suzanne E ^b   Loring, Jeanne F ^b  

^a UNIVERSITY OF NORTH TEXAS   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c NORTHEASTERN UNIVERSITY   (United States)

^d CSIRO   (Australia)

^e MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

LECTIN; LEUKOCYTE ANTIGEN; N ACETYLNEURAMINIC ACID; SIALYLTRANSFERASE; ST6GAL1 PROTEIN, HUMAN;

CELL DIFFERENTIATION; CYTOLOGY; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; GLYCOSYLATION; HUMAN; METABOLISM; PHYSIOLOGY; PLURIPOTENT STEM CELL;

ANTIGENS, CD; CELL DIFFERENTIATION; ENZYME ACTIVATION; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLYCOSYLATION; HUMANS; LECTINS; N-ACETYLNEURAMINIC ACID; PLURIPOTENT STEM CELLS; SIALYLTRANSFERASES;

EID: 84940042013     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep13317     Document Type: Article

References (49)

1. Wang, Y. C., Peterson, S. E., Loring, J. F. Protein post-translational modifications and regulation of pluripotency in human stem cells. Cell Res. 24, 143-160 (2014).
2. Schwarzkopf, M. et al. Sialylation is essential for early development in mice. P Natl Acad Sci USA. 99, 5267-5270 (2002).
3. Seth, A., Machingo, Q. J., Fritz, A., Shur, B. D. Core Fucosylation Is Required for Midline Patterning During Zebrafish Development. Dev Dynam. 239, 3380-3390 (2010).
4. Yan, Q. et al. O-fucose modulates Notch-controlled blood lineage commitment. Am J Pathol. 176, 2921-2934 (2010).
5. Jang, H. et al. O-GlcNAc Regulates Pluripotency and Reprogramming by Directly Acting on Core Components of the Pluripotency Network. Cell Stem Cell. 11, 62-74 (2012).
6. Hasehira, K. et al. Structural and Quantitative Evidence for Dynamic Glycome Shift on Production of Induced Pluripotent Stem Cells. Mol Cell Proteomics. 11, 1913-1923 (2012).
7. Satomaa, T. et al. The N-glycome of human embryonic stem cells. BMC Cell Biol. 10, doi: 10.1186/1471-2121-10-42 (2009).
8. Wang, Y. C. et al. Specific lectin biomarkers for isolation of human pluripotent stem cells identified through array-based glycomic analysis. Cell Res. 21, 1551-1563 (2011).
9. Saito, S. et al. Possible linkages between the inner and outer cellular states of human induced pluripotent stem cells. BMC Syst Biol. 5 Suppl 1, S17; doi: 10.1186/1752-0509-5-S1-S17 (2011).
10. Harduin-Lepers, A. Comprehensive Analysis of Sialyltransferases in Vertebrate Genomes. Glycobiol Insights. 2, 29-61; doi: 10.4137/GBI.S3123 (2010).
11. Harduin-Lepers, A. et al. The human sialyltransferase family. Biochimie. 83, 727-737 (2001).
12. Hedlund, M., Ng, E., Varki, A., Varki, N. M. alpha 2-6-Linked sialic acids on N-glycans modulate carcinoma differentiation in vivo. Cancer Res. 68, 388-394 (2008).
13. Tateno, H. et al. Glycome Diagnosis of Human Induced Pluripotent Stem Cells Using Lectin Microarray. J Biol Chem. 286, 20345-20353 (2011).
14. Alisson-Silva, F. et al. Evidences for the involvement of cell surface glycans in stem cell pluripotency and differentiation. Glycobiology. 24, 458-468 (2014).
15. International Stem Cell, I. et al. Characterization of human embryonic stem cell lines by the International Stem Cell Initiative. Nat Biotechnol. 25, 803-816 (2007).
16. Jones, J. C. et al. Melanocytes Derived from Transgene-Free Human Induced Pluripotent Stem Cells. J Invest Dermatol. 133, 2104-2108 (2013).
17. Vickers, D. A. et al. Lectin-functionalized microchannels for characterizing pluripotent cells and early differentiation. Biomicrofluidics. 6, 24122-2412210, doi: 10.1063/1.4719979 (2012).
18. Swindall, A. F. et al. ST6Gal-I Protein Expression Is Upregulated in Human Epithelial Tumors and Correlates with Stem Cell Markers in Normal Tissues and Colon Cancer Cell Lines. Cancer Res. 73, 2368-2378 (2013).
19. Cummings, R. D., Etzler, M. E. Antibodies and Lectins in Glycan Analysis in Essentials of Glycobiology 2nd edn (eds. Varki, A. et al.) Ch. 45 (Cold Spring Harbor Laboratory Press, 2009).
20. Bell, C. E., Watson, A. J. SNAI1 and SNAI2 Are Asymmetrically Expressed at the 2-Cell Stage and Become Segregated to the TE in the Mouse Blastocyst. PLoS One. 4, doi: 10.1371/journal.pone.0008530 (2009).
21. Demir, E. et al. Mutations in COL6A3 cause severe and mild phenotypes of Ullrich congenital muscular dystrophy. Am J Hum Genet. 70, 1446-1458 (2002).
22. Gherzi, R. et al. Akt2-mediated phosphorylation of Pitx2 controls Ccnd1 mRNA decay during muscle cell differentiation. Cell Death Differ. 17, 975-983 (2010).
23. Kiryushko, D. et al. Molecular mechanisms of Ca2+ signaling in neurons induced by the S100A4 protein. Mol Cell Biol. 26, 3625-3638 (2006).
24. Klein, D. et al. Hox genes are involved in vascular wall-resident multipotent stem cell differentiation into smooth muscle cells. Sci Rep-Uk. 3, doi: 10.1038/srep02178 (2013).
25. Wade, C. et al. Twist2 contributes to termination of limb bud outgrowth and patterning through direct regulation of Grem1. Dev Biol. 370, 145-153 (2012).
26. Scheper, W., Copray, S. The Molecular Mechanism of Induced Pluripotency: A Two-Stage Switch. Stem Cell Rev Rep. 5, 204-223 (2009).
27. Chia, N. Y. et al. A genome-wide RNAi screen reveals determinants of human embryonic stem cell identity. Nature. 468, 316-U207 (2010).
28. Montserrat, N. et al. Reprogramming of Human Fibroblasts to Pluripotency with Lineage Specifiers. Cell Stem Cell. 13, 341-350 (2013).
29. Wang, Z. et al. Distinct Lineage Specification Roles for NANOG, OCT4, and SOX2 in Human Embryonic Stem Cells. Cell Stem Cell. 10, 440-454 (2012).
30. Thomson, M. et al. Pluripotency Factors in Embryonic Stem Cells Regulate Differentiation into Germ Layers. Cell. 145, 875-889 (2011).
31. Donati, G., Montanaro, L., Derenzini, M. Ribosome biogenesis and control of cell proliferation: p53 is not alone. Cancer Res. 72, 1602-1607 (2012).
32. Iadevaia, V. et al. PIM1 kinase is destabilized by ribosomal stress causing inhibition of cell cycle progression. Oncogene. 29, 5490-5499 (2010).
33. Hong, H. et al. Suppression of induced pluripotent stem cell generation by the p53-p21 pathway. Nature. 460, 1132-1135 (2009).
34. Kawamura, T. et al. Linking the p53 tumour suppressor pathway to somatic cell reprogramming. Nature. 460, 1140-1144 (2009).
35. Van Hoof, D. et al. Phosphorylation dynamics during early differentiation of human embryonic stem cells. Cell Stem Cell. 5, 214-226 (2009).
36. Utikal, J. et al. Immortalization eliminates a roadblock during cellular reprogramming into iPS cells. Nature. 460, 1145-1148 (2009).
37. Rillahan, C. D. et al. Global metabolic inhibitors of sialyl-and fucosyltransferases remodel the glycome. Nat Chem Biol. 8, 661-668 (2012).
38. Chen, X., Varki, A. Advances in the biology and chemistry of sialic acids. ACS Chem Biol. 5, 163-176 (2010).
39. Schwarzkopf, M. et al. Sialylation is essential for early development in mice. Proc Natl Acad Sci USA. 99, 5267-5270 (2002).
40. Angata, T., Varki, A. Chemical diversity in the sialic acids and related alpha-keto acids: an evolutionary perspective. Chemical Rev. 102, 439-469 (2002).
41. Bock, C. et al. Reference Maps of human ES and iPS cell variation enable high-throughput characterization of pluripotent cell lines. Cell. 144, 439-452 (2011).
42. Chang, K. H. et al. Diverse hematopoietic potentials of five human embryonic stem cell lines. Exp Cell Res. 314, 2930-2940 (2008).
43. Chetty, S. et al. A simple tool to improve pluripotent stem cell differentiation. Nat Methods. 10, 553-556 (2013).
44. Osafune, K. et al. Marked differences in differentiation propensity among human embryonic stem cell lines. Nat Biotechnol. 26, 313-315 (2008).
45. Ma, H. et al. Reversal effect of ST6GAL 1 on multidrug resistance in human leukemia by regulating the PI3K/Akt pathway and the expression of P-gp and MRP1. PLoS One. 9, doi: 10.1371/journal.pone.0085113 (2014).
46. Zhao, Y. et al. Modification of sialylation mediates the invasive properties and chemosensitivity of human hepatocellular carcinoma. Mol Cell Proteomics. 13, 520-536 (2014).
47. Singh, A. M. et al. Signaling network crosstalk in human pluripotent cells: a Smad2/3-regulated switch that controls the balance between self-renewal and differentiation. Cell Stem Cell. 10, 312-326 (2012).
48. Morgado-Palacin, L., Llanos, S., Serrano, M. Ribosomal stress induces L11-and p53-dependent apoptosis in mouse pluripotent stem cells. Cell Cycle. 11, 503-510 (2012).
49. Watanabe-Susaki, K. et al. Biosynthesis of ribosomal RNA in nucleoli regulates pluripotency and differentiation ability of pluripotent stem cells. Stem Cells. 32, 3099-3111 (2014).